Advanced in Sepsis

Emmanuel Charbonney

Montreal, QC, CA 
Advanced in Sepsis
Montreal, QC, CA 
OverviewLocationsClinical Research

Overview

Emmanuel Charbonney practices in Montreal, Canada. Mr. Charbonney is rated as an Advanced expert by MediFind in the treatment of Sepsis. His top areas of expertise are Sepsis, Low Blood Pressure, Cerebral Hypoxia, and Acute Respiratory Distress Syndrome (ARDS).

His clinical research consists of co-authoring 92 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 13 articles in the study of Sepsis.

Gender
Male

Locations

Montreal, QC, Canada
Other Locations
Montreal, Canada
Toronto, ON, Canada
St. Michael's Hospital, Unity Health Toronto St. Michael's Hospital, Ottawa, ON, Canada
St. Joseph's Healthcare Hamilton, Ottawa, the Massawippi Valley Foundation, Ayer's Cliff, CHU Dr. Georges L. Dumont, Island Health Authority, Halton Healthcare
Oakville, ON, Canada
Edmundston, NB, Canada
1991 Boul, Trois Rivières, Carmel, QC G8Z3R9, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Proportional Assist Ventilation for Minimizing the Duration of Mechanical Ventilation: The PROMIZING Study
Proportional Assist Ventilation for Minimizing the Duration of Mechanical Ventilation: The PROMIZING Study
Enrollment Status: Completed
Publish Date: May 22, 2025
Intervention Type: Other
Study Phase: Not Applicable
Re-EValuating the Inhibition of Stress Erosions: Prophylaxis Against Gastrointestinal Bleeding in the Critically Ill (The REVISE) Trial
Re-EValuating the Inhibition of Stress Erosions: Prophylaxis Against Gastrointestinal Bleeding in the Critically Ill (The REVISE) Trial
Enrollment Status: Completed
Publish Date: September 20, 2024
Intervention Type: Drug
Study Drug: Pantoprazole
Study Phase: Phase 3
Non-invasive Assessment to Predict Tolerance to Fluid Removal on Intermittent Kidney Replacement Therapy
Non-invasive Assessment to Predict Tolerance to Fluid Removal on Intermittent Kidney Replacement Therapy
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Diagnostic test
Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT)
Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT)
Enrollment Status: Completed
Publish Date: December 17, 2020
Intervention Type: Drug
Study Phase: Phase 4
View 3 Less Clinical Trials

92 Total Publications

Uric acid and ammonia play synergistic roles in the loss of blood-brain barrier integrity in the context of hepatic encephalopathy.
Uric acid and ammonia play synergistic roles in the loss of blood-brain barrier integrity in the context of hepatic encephalopathy.
Journal: Fluids and barriers of the CNS
Published: September 04, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Charbonney's expertise for a condition
ConditionClose
      View All 13 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile